As of 2024-07-27, the Relative Valuation of Intra-Cellular Therapies Inc (ITCI) is (14.13) USD. This relative valuation is based on P/E multiples. With the latest stock price at 80.39 USD, the upside of Intra-Cellular Therapies Inc based on Relative Valuation is -117.6%.
The range of the Relative Valuation is (10.61) - (15.47) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.2x - 14.7x | 10.2x |
| Forward P/E multiples | 10.1x - 20.5x | 16.7x |
| Fair Price | (10.61) - (15.47) | (14.13) |
| Upside | -113.2% - -119.2% | -117.6% |
| Date | P/E |
| 2024-07-26 | -76.51 |
| 2024-07-25 | -76.94 |
| 2024-07-24 | -73.54 |
| 2024-07-23 | -74.42 |
| 2024-07-22 | -72.79 |
| 2024-07-19 | -71.25 |
| 2024-07-18 | -71.32 |
| 2024-07-17 | -72.82 |
| 2024-07-16 | -74.78 |
| 2024-07-15 | -74.89 |
| 2024-07-12 | -74.36 |
| 2024-07-11 | -74.54 |
| 2024-07-10 | -73.56 |
| 2024-07-09 | -70.49 |
| 2024-07-08 | -68.10 |
| 2024-07-05 | -66.20 |
| 2024-07-03 | -65.73 |
| 2024-07-02 | -65.23 |
| 2024-07-01 | -64.71 |
| 2024-06-28 | -65.18 |
| 2024-06-27 | -67.55 |
| 2024-06-26 | -67.66 |
| 2024-06-25 | -68.92 |
| 2024-06-24 | -71.92 |
| 2024-06-21 | -72.88 |
| 2024-06-20 | -71.90 |
| 2024-06-18 | -71.84 |
| 2024-06-17 | -65.54 |
| 2024-06-14 | -64.50 |
| 2024-06-13 | -65.11 |
| 2024-06-12 | -64.91 |
| 2024-06-11 | -65.79 |
| 2024-06-10 | -65.73 |
| 2024-06-07 | -65.11 |
| 2024-06-06 | -65.24 |
| 2024-06-05 | -64.54 |
| 2024-06-04 | -64.60 |
| 2024-06-03 | -65.11 |
| 2024-05-31 | -63.99 |
| 2024-05-30 | -62.48 |
| 2024-05-29 | -63.33 |
| 2024-05-28 | -62.45 |
| 2024-05-24 | -62.38 |
| 2024-05-23 | -63.17 |
| 2024-05-22 | -64.05 |
| 2024-05-21 | -63.76 |
| 2024-05-20 | -62.17 |
| 2024-05-17 | -61.86 |
| 2024-05-16 | -63.32 |
| 2024-05-15 | -63.61 |